Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube

Explore clinical trials studying Fallopian Tube. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Fallopian Tube trial results

Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT04606914

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • University of Alabama at Birmingham Womens & Infants Center Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Minnesota - Masonic Cancer Center Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies

NCT01974765

Conditions
Advanced Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, +1 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer

NCT02737787

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01339650

Conditions
Fallopian Tube, Fanconi Anemia, Complementation Group D1, Primary Peritoneal Cancer, +1 more
Locations
  • Univ Med Center Groningen Groningen, Netherlands
  • Univ Med Ctr, St. Radboud Nijmegen, Netherlands
  • Erasmus Medisch Centrum Rotterdam, Netherlands
View Trial Details

Related conditions